Edwards Lifesciences Corp at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 07:15PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst

(technical difficulty) I think it's over 20 that you've been at. So I'll turn it over to you, Mike, and then we'll do some Q&A.

Michael A. Mussallem - Edwards Lifesciences Corporation - Chairman & CEO

Thanks, Robbie, and welcome all. It's a pleasure to be here. Yes, we've done this a few times, and it's been a pleasure. I always love to talk about our company before we get into it. We're going to be making some forward-looking statements, which involve risks. We've got all of those lists on our website and filed with the SEC. So feel free to take a look and we also use non-GAAP financial measures to make our P&L more understandable for all of you, and those are also available in our filings and on our website.

So the credo is not something we just used for these kind of presentations. We talk about it inside the company all the time. It's been with us since the Edwards birth when we rang the bell April 3rd of 2000. And you can see it's a multi-stakeholder model,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot